Saturday, November 14

    Accounting

    Nov. 13, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (Inhibrx or the Company) today reported financial results for the third quarter of 2026. The biopharmaceutical company has two programs in ongoing clinical trials

    eCommerce

    The Zacks Retail-Home Furnishings industry continues to face headwinds from subdued housing activity, cautious consumer spending and persistent economic uncertainty. Elevated borrowing costs and affordability concerns are delaying furniture purchases, renovations and other discretionary home-related expenditures. Demand remains particularly weak among middle-income consumers, while higher-income households continue to support premium product sales. Meanwhile, tariff uncertainties,…

    CRM

    AI Tools

    Read More